BIOMAT Database Logo BIOMAT Database Logo

4- and 5-aroylindoles as novel classes of potent antitubulin agents. 2007

Jing-Ping Liou, and Chang-Ying Wu, and Hsing-Pang Hsieh, and Chi-Yen Chang, and Chi-Ming Chen, and Ching-Chuan Kuo, and Jang-Yang Chang
College of Pharmacy, Taipei Medical University, Taipei 110, Taiwan, Republic of China.

A novel series of 4- and 5-aroylindole derivatives was prepared and evaluated for antitumor activity. Several compounds showed excellent antiproliferative activity as inhibitors of tubulin polymerization. Compounds 13, 14, 15, and 18, with IC50 values of 1.9, 1.1, 1.2, and 1.8 microM, respectively, exhibited more potent inhibition of tubulin polymerization than colchicine. They also displayed antiproliferative activity, with IC50 values ranging from 10 to 43 nM in a variety of human cell lines from different organs.

UI MeSH Term Description Entries
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D003078 Colchicine A major alkaloid from Colchicum autumnale L. and found also in other Colchicum species. Its primary therapeutic use is in the treatment of gout, but it has been used also in the therapy of familial Mediterranean fever (PERIODIC DISEASE). Colchicine, (+-)-Isomer,Colchicine, (R)-Isomer
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D001704 Biopolymers Polymers synthesized by living organisms. They play a role in the formation of macromolecular structures and are synthesized via the covalent linkage of biological molecules, especially AMINO ACIDS; NUCLEOTIDES; and CARBOHYDRATES. Bioplastics,Bioplastic,Biopolymer
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular

Related Publications

Jing-Ping Liou, and Chang-Ying Wu, and Hsing-Pang Hsieh, and Chi-Yen Chang, and Chi-Ming Chen, and Ching-Chuan Kuo, and Jang-Yang Chang
Concise synthesis and structure-activity relationships of combretastatin A-4 analogues, 1-aroylindoles and 3-aroylindoles, as novel classes of potent antitubulin agents.
August 2004, Journal of medicinal chemistry,
Jing-Ping Liou, and Chang-Ying Wu, and Hsing-Pang Hsieh, and Chi-Yen Chang, and Chi-Ming Chen, and Ching-Chuan Kuo, and Jang-Yang Chang
Structure-activity relationship studies of 3-aroylindoles as potent antimitotic agents.
October 2006, ChemMedChem,
Jing-Ping Liou, and Chang-Ying Wu, and Hsing-Pang Hsieh, and Chi-Yen Chang, and Chi-Ming Chen, and Ching-Chuan Kuo, and Jang-Yang Chang
7-Aroyl-aminoindoline-1-sulfonamides as a novel class of potent antitubulin agents.
November 2006, Journal of medicinal chemistry,
Jing-Ping Liou, and Chang-Ying Wu, and Hsing-Pang Hsieh, and Chi-Yen Chang, and Chi-Ming Chen, and Ching-Chuan Kuo, and Jang-Yang Chang
Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxybenzoyl)-5-aryl thiophenes as a new class of potent antitubulin agents.
June 2006, Journal of medicinal chemistry,
Jing-Ping Liou, and Chang-Ying Wu, and Hsing-Pang Hsieh, and Chi-Yen Chang, and Chi-Ming Chen, and Ching-Chuan Kuo, and Jang-Yang Chang
Design, Synthesis and Antitumor Activity of Novel link-bridge and B-Ring Modified Combretastatin A-4 (CA-4) Analogues as Potent Antitubulin Agents.
May 2016, Scientific reports,
Jing-Ping Liou, and Chang-Ying Wu, and Hsing-Pang Hsieh, and Chi-Yen Chang, and Chi-Ming Chen, and Ching-Chuan Kuo, and Jang-Yang Chang
IsoCombretaQuinazolines: Potent Cytotoxic Agents with Antitubulin Activity.
August 2015, ChemMedChem,
Jing-Ping Liou, and Chang-Ying Wu, and Hsing-Pang Hsieh, and Chi-Yen Chang, and Chi-Ming Chen, and Ching-Chuan Kuo, and Jang-Yang Chang
Design, synthesis, and evaluation of novel thienopyrrolizinones as antitubulin agents.
March 2004, Journal of medicinal chemistry,
Jing-Ping Liou, and Chang-Ying Wu, and Hsing-Pang Hsieh, and Chi-Yen Chang, and Chi-Ming Chen, and Ching-Chuan Kuo, and Jang-Yang Chang
Novel [1,2,4]triazolo[1,5-a]pyrimidine derivatives as potent antitubulin agents: Design, multicomponent synthesis and antiproliferative activities.
November 2019, Bioorganic chemistry,
Jing-Ping Liou, and Chang-Ying Wu, and Hsing-Pang Hsieh, and Chi-Yen Chang, and Chi-Ming Chen, and Ching-Chuan Kuo, and Jang-Yang Chang
CuI-mediated synthesis of 1-aryl-5,6,7-trimethoxybenzimidazoles as potent antitubulin agents.
April 2023, RSC advances,
Jing-Ping Liou, and Chang-Ying Wu, and Hsing-Pang Hsieh, and Chi-Yen Chang, and Chi-Ming Chen, and Ching-Chuan Kuo, and Jang-Yang Chang
Discovery and Optimization of Novel 5-Indolyl-7-arylimidazo[1,2-a]pyridine-8-carbonitrile Derivatives as Potent Antitubulin Agents Targeting Colchicine-binding Site.
February 2017, Scientific reports,
Copied contents to your clipboard!